141 related articles for article (PubMed ID: 9067922)
1. Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis fluids on leukocytes cell functions.
Mahiout A; Matata BM; Brunkhorst R
Kidney Int; 1997 Mar; 51(3):860-7. PubMed ID: 9067922
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate anions neutralize peritoneal dialysate cytotoxicity.
Mahiout A; Brunkhorst R
Nephrol Dial Transplant; 1995; 10(3):391-4. PubMed ID: 7792037
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.
Cendoroglo M; Sundaram S; Jaber BL; Pereira BJ
Am J Kidney Dis; 1998 Feb; 31(2):273-82. PubMed ID: 9469498
[TBL] [Abstract][Full Text] [Related]
4. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
5. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate neutralizes peritoneal dialysate cytotoxicity: maintained integrity and proliferation of cultured human mesothelial cells.
Brunkhorst R; Mahiout A
Kidney Int; 1995 Jul; 48(1):177-81. PubMed ID: 7564075
[TBL] [Abstract][Full Text] [Related]
7. The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes.
Douvdevani A; Rapoport J; Konforti A; Zlotnik M; Chaimovitz C
Perit Dial Int; 1993; 13(2):112-7. PubMed ID: 8494931
[TBL] [Abstract][Full Text] [Related]
8. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
9. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
10. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
11. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
13. Effects of commercial glucose-based peritoneal dialysates on peripheral blood phagocytes apoptosis.
Jin HM; Di YD; Xu QJ
Perit Dial Int; 1999; 19 Suppl 2():S388-93. PubMed ID: 10406552
[TBL] [Abstract][Full Text] [Related]
14. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.
Jörres A; Gahl GM; Topley N; Neubauer A; Ludat K; Müller C; Passlick-Deetjen J
Nephrol Dial Transplant; 1994; 9(7):785-90. PubMed ID: 7970120
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.
Jörres A; Topley N; Steenweg L; Müller C; Köttgen E; Gahl GM
Am J Nephrol; 1992; 12(1-2):80-5. PubMed ID: 1415370
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose.
Albrektsson A; Bazargani F; Wieslander A; Braide M
ASAIO J; 2006; 52(3):276-81. PubMed ID: 16760716
[TBL] [Abstract][Full Text] [Related]
17. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
[TBL] [Abstract][Full Text] [Related]
18. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
[TBL] [Abstract][Full Text] [Related]
19. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
[TBL] [Abstract][Full Text] [Related]
20. In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.
Mackenzie RK; Jones S; Moseley A; Holmes CJ; Argyle R; Williams JD; Coles GA; Pu K; Faict D; Topley N
Am J Kidney Dis; 2000 Jan; 35(1):112-21. PubMed ID: 10620552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
